Skip to main content
. 2018 Jun 22;119(3):388. doi: 10.1038/s41416-018-0146-2

Fig. 4.

Fig. 4

Effect of miR-1260b knockdown on prostate cancer cells (PC-3, DU-145). Two prostate cancer cell lines (PC-3 and DU-145) were transiently transfected with either miR-1260b inhibitor or miR-negative control (miR-NC inhibitor). a Relative miR-1260b expression (miR-NC inhibitor or miR-1260b inhibitor transfected PC cells), b cell viability assay (miR-NC inhibitor or miR-1260b inhibitor transfected PC cells), c invasion assay, d wound healing assay (16–17 h). e Apoptosis assay, f cell cycle analysis, g TCF reporter assay. Error bars represent ±s.d